產(chǎn)品名稱：T-HESCs人子宮內(nèi)膜間質(zhì)細胞、T-HESCs人子宮內(nèi)膜間質(zhì)細胞、T-HESCs人子宮內(nèi)膜間質(zhì)細胞、T-HESCs人子宮內(nèi)膜間質(zhì)細胞；


ranging from mild maculopapular exanthema (MPE) to life-threatening severe CADRs (S-CADRs). Due to their unpredictability and severity, early recognition of suspected causative drukl is highly recommended. However, the profile of CADRs remains unknown in China.
Objectives: To assess the clinical profile, predominant causative drukl, and cost associated with CADRs in